INVESTORS
Telix Pharmaceuticals Limited (ASX:TLX) is backed by committed investors with a strong belief in Telix’s healthcare mission.
Telix Pharmaceuticals Limited Corporate Video
Annual General Meeting
Date: Wednesday 12 May 2021
Time: 11.30am AEST
The AGM will be convened at The Events Centre, Collins Square, 727 Collins Street, Melbourne VIC 3008 and via teleconference here: https://agmlive.link/TLX21
Under Rule 7.3(d) of the Company’s Constitution, Shareholders attending the hybrid Annual General Meeting will be able to hear and view the Annual General Meeting on their own devices, vote on resolutions and ask questions and will be treated as if they were present at the physical location of the Annual General Meeting.
The business to be considered at the Annual General Meeting is set out in the Notice of Meeting.
For further information on joining the hybrid meeting please read the Online Guide.
Compliance
The Board of Telix Pharmaceuticals recognises that an effective and efficient governance framework provides a solid structure for transparent decision making and is fundamental to the sustainability of our business and long-term performance.
In keeping with this, the Board embraces principles it considers to be best practice internationally and uses the guidance provided by the ASX Corporate Governance Council as a focus for the development and continuous improvement of the Company’s governance framework, policies, and practices.
- Telix – Board charter and relationship with management
- Audit and Risk Committee Charter
- Nomination and Remuneration Committee Charter
- Whistleblower Protection Policy
- Code of Conduct
- Continuous Disclosure Policy
- Securities Dealing Policy
- Corporate Governance Statement 26.02.21
- Telix Pharmaceuticals Limited Constitution
- Diversity Policy